A new case series published in the journal Frontiers in Neuroscience details how cannabis-based products led to seizure freedom in nearly a dozen pediatric and adult patients with drug-resistant epilepsy (DRE). Conducted by researchers at the University of Toronto and University Health Network, the retrospective study evaluated 19 patients with DRE—15 of them children—who experienced …
Category: News
CNBC’s Jim Cramer Calls Aurora Cannabis “a Nice Speculative Stock”
During a recent segment of CNBC’s Mad Money, host Jim Cramer gave a cautiously optimistic take on Aurora Cannabis, calling it “a nice speculative stock.” Cramer made the comments in response to a viewer named Eric from New York, who called in saying: “My question, ECB Aurora Cannabis.” Cramer replied: “You know I keep thinking …
California Assembly Unanimously Passes Bill to Delay Marijuana Excise Tax Increase
The California Assembly has unanimously passed legislation to delay a planned increase in the state’s cannabis excise tax. Introduced by Assemblymember Matt Haney, Assembly Bill 564 would postpone scheduled changes to the state’s marijuana excise tax until the 2030–31 fiscal year. The proposal was passed by the Assembly 74 to 0, sending it to the …
Study: Combination of CBD and Hydroxychloroquine Found Safe and Bioavailable in Phase I Trial
A phase I clinical trial has found that a novel combination of cannabidiol (CBD) and hydroxychloroquine (HCQ), known as IHL-675 A, is well tolerated and bioavailable in healthy volunteers, supporting further investigation in inflammatory conditions such as rheumatoid arthritis. The trial involved 36 participants who were randomly assigned to receive either IHL-675 A, Epidiolex (CBD), …
Study: Aesthetic Elements of Psychedelic Experiences Strongly Linked to Psychological Benefits
A new study finds that the aesthetic quality of psychedelic experiences—such as vivid visual imagery and emotional beauty—may be a key factor in promoting therapeutic benefits. Researchers at the University of Colorado surveyed 96 individuals who had used classic psychedelics like psilocybin, LSD, DMT, or mescaline within the past year. Participants completed several psychological assessments, …
Study: Strong Majority of Psychiatric Patients Open to Psilocybin Therapy, Including Non-Hallucinogenic Options
A majority of psychiatric patients support the idea of psilocybin therapy, with many showing a willingness to try non-hallucinogenic forms, according to new research published in the Journal of Psychoactive Drugs. The study, conducted by researchers at Wright State University, surveyed patients aged 18 to 65 at a community mental health center to assess their …
Mississippi Band of Choctaw Indians to Vote Next Week on Marijuana Legalization
The Mississippi Band of Choctaw Indians is just days away from voting on a proposal to legalize recreational marijuana on tribal land for everyone 21 and older. Scheduled for a special election on June 10, Referendum No. 2025-01 would allow adults to possess, produce, and distribute marijuana within the tribe’s jurisdiction. Although the referendum would …
Florida Medical Cannabis Sales Reach $157 Million in May, Pushing 2025 Total to $750 Million
Florida’s medical marijuana market generated $157,368,038 in sales during May, according to figures released today by the research firm Headset. With May’s numbers now in, Florida’s 2025 marijuana sales total $748,497,423. This includes revised totals of $155,307,418 for April, $150,896,110 for March, $139,346,318 for February, and $145,579,539 for January. Dried marijuana flower once again accounted …
Ohio House Committee Sets June 4 Hearing on Bill to Roll Back Voter-Approved Marijuana Law
The House Judiciary Committee in Ohio has scheduled a public hearing for Wednesday, June 4 on Senate Bill 56, a proposal to roll-back portions of the state’s voter-approved cannabis legalization law. The hearing is scheduled for 9:00 a.m. on June 4 in Room 313 of the State House, with SB 56 listed second on the …
Federal Judge Rejects Oregon’s Attempt to Dismiss Psilocybin ADA Lawsuit
A federal judge has denied the Oregon Health Authority’s motion to dismiss a lawsuit that challenges the state’s refusal to allow home-based psilocybin services for people with disabilities. Filed by four trained or licensed psilocybin facilitators, the lawsuit claims Oregon’s psilocybin regulations violate the Americans with Disabilities Act (ADA) by failing to accommodate clients who …
Sponsored
